CD8+ cells in malignant tumors have been associated with an improved DSS in: non-small cell lung carcinoma; carcinomas of the endometrium, bile duct, colon, oesophagus, and urothelium; uveal melanoma; and follicular lymphoma [22,31-40]. The gene discussed is CD8A; the disease is follicular lymphoma.